Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NOVAVAX INC | Director | Common Stock | 43.9K | $610K | $13.90 | Jun 12, 2024 | Direct |
MAXCYTE, INC. | Director | Common Stock | 121K | $595K | $4.90 | Jun 11, 2024 | Direct |
NOVAVAX INC | Director | Stock Option (Right to Buy) | 15.6K | $248K | $15.86 | Jun 12, 2024 | Direct |
NOVAVAX INC | Director | Restricted Stock Units | 10.4K | $145K | $13.90 | Jun 12, 2024 | Direct |
MAXCYTE, INC. | Director | Stock Option (right to buy) | 40.7K | Jun 11, 2024 | Direct | ||
Aldeyra Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 1.22K | Jun 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NVAX | NOVAVAX INC | Jun 12, 2024 | 4 | $248K | 4 | Jun 14, 2024 | Director |
MXCT | MAXCYTE, INC. | Jun 11, 2024 | 2 | $0 | 4 | Jun 13, 2024 | Director |
ALDX | Aldeyra Therapeutics, Inc. | Jun 4, 2024 | 3 | $0 | 4 | Jun 6, 2024 | Director |
ALDX | Aldeyra Therapeutics, Inc. | Jun 30, 2023 | 3 | $0 | 4 | Jul 5, 2023 | Director |
MXCT | MAXCYTE, INC. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
NVAX | NOVAVAX INC | Jun 10, 2023 | 4 | $0 | 4 | Jun 13, 2023 | Director |
MXCT | MAXCYTE, INC. | Mar 29, 2023 | 1 | $345K | 4 | Mar 30, 2023 | Director |
MXCT | MAXCYTE, INC. | Jun 29, 2022 | 1 | $0 | 4 | Jul 8, 2022 | Director |
NVAX | NOVAVAX INC | Jun 17, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
NVAX | NOVAVAX INC | Jun 10, 2022 | 2 | $0 | 4 | Jun 14, 2022 | Director |
ALDX | Aldeyra Therapeutics, Inc. | Jun 7, 2022 | 3 | $0 | 4 | Jun 9, 2022 | Director |
NVAX | NOVAVAX INC | Dec 13, 2021 | 2 | $38.4K | 4 | Dec 15, 2021 | Director |
MXCT | MAXCYTE, INC. | Nov 22, 2021 | 1 | $222K | 4 | Nov 23, 2021 | Director |
MXCT | MAXCYTE, INC. | Aug 9, 2021 | 1 | $0 | 4 | Aug 11, 2021 | Director |
MXCT | MAXCYTE, INC. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |
NVAX | NOVAVAX INC | Jun 25, 2021 | 2 | $0 | 4 | Jun 29, 2021 | Director |
NVAX | NOVAVAX INC | Jun 17, 2021 | 2 | $0 | 4 | Jun 22, 2021 | Director |
ALDX | Aldeyra Therapeutics, Inc. | Jun 8, 2021 | 3 | $0 | 4 | Jun 10, 2021 | Director |